1. Home
  2. VWAV vs CVM Comparison

VWAV vs CVM Comparison

Compare VWAV & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VisionWave Holdings Inc.

VWAV

VisionWave Holdings Inc.

N/A

Current Price

$2.58

Market Cap

36.4M

Sector

Technology

ML Signal

N/A

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

N/A

Current Price

$1.38

Market Cap

30.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VWAV
CVM
Founded
2024
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.4M
30.6M
IPO Year
2025
1996

Fundamental Metrics

Financial Performance
Metric
VWAV
CVM
Price
$2.58
$1.38
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $12.50
AVG Volume (30 Days)
197.1K
★ 252.6K
Earning Date
08-19-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 65.45
52 Week Low
$0.26
$0.89
52 Week High
$79,000.00
$7.80

Technical Indicators

Market Signals
Indicator
VWAV
CVM
Relative Strength Index (RSI) 19.39 35.99
Support Level $0.26 $1.34
Resistance Level $5.79 $1.52
Average True Range (ATR) 0.56 0.14
MACD 130.16 -0.04
Stochastic Oscillator 17.14 7.00

Price Performance

Historical Comparison
VWAV
CVM

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: